Literature DB >> 9745927

Glutamate-stimulated ROS production in neuronal cultures: interactions with lead and the cholinergic system.

K M Savolainen1, J Loikkanen, S Eerikäinen, J Naarala.   

Abstract

Oxidative stress may be an important factor in several pathological brain conditions. A contributing factor in many such conditions is excessive glutamate release, and subsequent glutamatergic neuronal stimulation, that causes increased production of reactive oxygen species (ROS), oxidative stress, excitotoxicity and neuronal damage. Glutamate release is also associated with illnesses such as Alzheimer's disease, stroke, and brain injury. Glutamate may interact with an environmental toxin, lead, and this interaction may result in neuronal damage. Glutamate-induced ROS production is greatly amplified by lead in cultured neuronal cells. Alterations in protein kinase C (PKC) activity seem to be important both for glutamate-induced ROS production, and for the amplification of glutamate-induced ROS production by lead. It is possible that the neurotoxic effects of lead are amplified through glutamate-induced neuronal excitation. Cholinergic stimulation can also trigger ROS production in neuronal cells. PKC seems to play a key-role also in cholinergic-induced ROS production superoxide anion being the primary reactive oxygen species. There seems to be a close relationship between the responses of cholinergic muscarinic and glutamatergic receptors because glutamate receptor antagonists inhibit cholinergic-induced activation of human neuroblastoma cells. Glutamatergic neuronal stimulation may be a common final pathway in several brain conditions in which oxidative stress and ensuing excitotoxicity plays a role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745927

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  8 in total

1.  A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway.

Authors:  Tao Pang; Yun-Jie Wang; Yuan-Xue Gao; Yuan Xu; Qiu Li; Yu-Bo Zhou; Lei Xu; Zhang-Jian Huang; Hong Liao; Lu-Yong Zhang; Jian-Rong Gao; Qing Ye; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2016-04-25       Impact factor: 6.150

2.  Reply to Salari et al.: Toward understanding the deep mechanisms regarding the biophotons related to human intelligence.

Authors:  Jiapei Dai; Zhuo Wang; Zehua Li; Fangyan Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

3.  Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.

Authors:  Deepali Gupta; Mahesh Radhakrishnan; Yeshwant Kurhe; Devadoss Thangaraj; Visakh Prabhakar; Prateek Kanade
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

4.  Pyrroloquinoline quinine protects rat brain cortex against acute glutamate-induced neurotoxicity.

Authors:  Qi Zhang; Mei Ding; Zheng Cao; Jingjing Zhang; Fei Ding; Kaifu Ke
Journal:  Neurochem Res       Date:  2013-05-18       Impact factor: 3.996

Review 5.  The role of oxidative stress in anxiety disorder: cause or consequence?

Authors:  Alessandra das Graças Fedoce; Frederico Ferreira; Robert G Bota; Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Res       Date:  2018-06-04

6.  Glioprotective effects of Ashwagandha leaf extract against lead induced toxicity.

Authors:  Praveen Kumar; Raghavendra Singh; Arshed Nazmi; Dinesh Lakhanpal; Hardeep Kataria; Gurcharan Kaur
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

7.  Posttranslational nitration of tyrosine residues modulates glutamate transmission and contributes to N-methyl-D-aspartate-mediated thermal hyperalgesia.

Authors:  Carolina Muscoli; Concetta Dagostino; Sara Ilari; Filomena Lauro; Micaela Gliozzi; Erlisa Bardhi; Ernesto Palma; Vincenzo Mollace; Daniela Salvemini
Journal:  Mediators Inflamm       Date:  2013-06-20       Impact factor: 4.711

8.  Glutaminase 1 Regulates Neuroinflammation After Cerebral Ischemia Through Enhancing Microglial Activation and Pro-Inflammatory Exosome Release.

Authors:  Ge Gao; Congcong Li; Jie Zhu; Yi Wang; Yunlong Huang; Shu Zhao; Shiyang Sheng; Yu Song; Chenhui Ji; Chunhong Li; Xiaoyu Yang; Ling Ye; Xinrui Qi; Yanyan Zhang; Xiaohuan Xia; Jialin C Zheng
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.